CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | GOREVIC JASON N CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −5,615 | 22,460 | ||
| 2024-03-01 | GOREVIC JASON N CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −62,004 | 124,008 | ||
| 2024-03-01 | GOREVIC JASON N CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −7,648 | 0 | ||
| 2024-03-01 | Nanis Nikolaos P. Chief Technology Officer | Option exercise | +1,479 | 66,510 | ||
| 2024-03-01 | Nanis Nikolaos P. Chief Technology Officer | Option exercise | +505 | 67,015 | ||
| 2024-03-01 | Nanis Nikolaos P. Chief Technology Officer | Option exercise | +894 | 67,909 | ||
| 2024-03-01 | Nanis Nikolaos P. Chief Technology Officer | Option exercise | +4,340 | 72,249 | ||
| 2024-03-01 | Nanis Nikolaos P. Chief Technology Officer | Option exercise | +467 | 72,716 | ||
| 2024-03-01 | Nanis Nikolaos P. Chief Technology Officer | Grant or award · Performance Stock Units | +4,437 | 4,437 | ||
| 2024-03-01 | Nanis Nikolaos P. Chief Technology Officer | Option exercise · Performance Stock Units | −1,479 | 2,958 | ||
| 2024-03-01 | Nanis Nikolaos P. Chief Technology Officer | Option exercise · Restricted Stock Units | −505 | 2,023 | ||
| 2024-03-01 | Nanis Nikolaos P. Chief Technology Officer | Option exercise · Restricted Stock Units | −894 | 4,472 | ||
| 2024-03-01 | Nanis Nikolaos P. Chief Technology Officer | Option exercise · Restricted Stock Units | −4,340 | 8,681 | ||
| 2024-03-01 | Nanis Nikolaos P. Chief Technology Officer | Option exercise · Restricted Stock Units | −467 | 0 | ||
| 2024-03-01 | Raman-Tangella Vidya CHIEF MEDICAL OFFICER | Option exercise | +3,169 | 17,906 | ||
| 2024-03-01 | Raman-Tangella Vidya CHIEF MEDICAL OFFICER | Option exercise | +9,300 | 27,206 | ||
| 2024-03-01 | Raman-Tangella Vidya CHIEF MEDICAL OFFICER | Grant or award · Performance Stock Units | +9,509 | 9,509 | ||
| 2024-03-01 | Raman-Tangella Vidya CHIEF MEDICAL OFFICER | Option exercise · Performance Stock Units | −3,169 | 6,340 | ||
| 2024-03-01 | Raman-Tangella Vidya CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −9,300 | 18,602 | ||
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Sale 10b5-1 | −475 | $15.06 | $7K | 25,193 |
Page 37 of 74 · 1,476 trades